Samsung Biologics Reports First Quarter 2026 Financial Results ...Middle East

PR Newswire - News
Samsung Biologics Reports First Quarter 2026 Financial Results

Recorded Q1'26 revenue of KRW 1,257 billion and operating profit of KRW 581 billion Performance driven by full utilization across Plants 1 through 4 and robust operational execution Strengthened the foundations for future growth through U.S. expansion and strategic partnerships INCHEON,...

    Hence then, the article about samsung biologics reports first quarter 2026 financial results was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Samsung Biologics Reports First Quarter 2026 Financial Results )

    Apple Storegoogle play

    Last updated :

    Also on site :